Advertisement

Topics

Rockefeller & Co., Inc. Company Profile

21:07 EST 19th November 2017 | BioPortfolio

Headquartered in New York and with offices in Boston, Washington D.C. and Wilmington, Delaware, Rockefeller and Company is a leading global wealth management firm that provides comprehensive wealth and investment management services to a diversified client base of high net worth individuals, families, trusts, foundations and endowments. Independent and privately-owned, the firm has three wholly owned subsidiaries: Rockefeller Trust Company, N.A., a national limited purpose trust company, The Rockefeller Trust Company (Delaware), a Delaware limited purpose trust company, and Rockit Solutions, LLC, a leading provider of wealth data aggregation and reporting solutions for single-family and multi-family offices, high net worth individuals and financial institutions. Rockefeller and Company was incorporated in 1979 and registered with the Securities and Exchange Commission in 1980 as an investment adviser. As of September 30, 2009, the firm and its subsidiaries had approximately $24 billion in assets under administration.


News Articles [36 Associated News Articles listed on BioPortfolio]

Media Advisory: Press Conference on October 2 with Michael Young of The Rockefeller University, winner of the 2017 Nobel Prize in Physiology or Medicine

NEW YORK, Oct. 2, 2017 /PRNewswire-USNewswire/ -- The Rockefeller University is holding a press conference with Michael Young, a recipient of this year's Nobel Prize in Physiology or Medicine. ...

Rockefeller University biologist Michael W. Young honored with Nobel Prize

(Rockefeller University) Rockefeller University biologist Michael W. Young, who studies the biological clocks that regulate sleep, metabolism, and response to disease, is this year's recipient of the ...

Frontier gets worldwide rights to Rockefeller U.'s 3BNC117 for use in combo HIV therapy

Frontier Biotechnologies Inc. received global rights to combine Rockefeller University's broad-spectrum HIV-neutralizing antibody 3BNC117 with its own albuvirtide for the treatment and prophylaxis of ...

Rockefeller Foundation backs nonprofit ETF startup

NEW YORK (Reuters) - The Rockefeller Foundation is helping to finance a startup hoping to build exchange-traded funds for nonprofit organizations and direct the profits back to their causes, officials...

Nanjing Frontier Acquires Rights to Rockefeller University HIV/AIDS Antibody

Nanjing Frontier Biotechnologies acquired global rights to a novel broad-spectrum HIV neutralizing antibody from The Rockefeller University of the US. Frontier will combine the antibody with albuvirti...

Cerevance Licenses Human Brain Tissue Profiling Technology from The Rockefeller University

Cerevance, a drug discovery and development company focused on brain diseases, today announced that it has signed an agreement with The Rockefeller University to license a novel t...

Nanjing Frontier Acquires Rights To Rockefeller University HIV/AIDS Antibody

  Life Sciences Jobs   ...

Simple strategy could lead to a universal flu vaccine

Drugs and Medications [0 Results]

None

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Alan Gregg, the Diary of a Thoughtful Eye-Witness.

After two years of discussions and delays surrounding his eventual departure, Alan Gregg, the 37-year-old associate director of the Rockefeller Foundation's Division of Medical Education (DME), set ou...

Toxicity of spinosad to temephos-resistant Aedes aegypti populations in Brazil.

The mosquito Aedes aegypti is the primary vector of different arboviruses and represents a major public health problem. Several Brazilian populations of Ae. aegypti have developed resistance to temeph...

A Video-Tracking Analysis-Based Behavioral Assay for Larvae of Anopheles pseudopunctipennis and Aedes aegypti (Diptera: Culicidae).

Aedes aegypti (L.) is the primary vector of dengue, yellow fever, Zika, and chikungunya viruses, whereas Anopheles pseudopunctipennis (Theobald) is the principal vector for malaria in Latin America. T...

Gateways to the Laboratory: How an MD-PhD Program Increased the Number of Minority Physician-Scientists.

Traditional underrepresented minority (URM) groups (African Americans, Hispanic Americans, Native Americans) remain underrepresented among physician-scientists. To address the dearth of URM physician-...

Interrogating resilience in health systems development.

The Fourth Global Symposium on Health Systems Research was themed around 'Resilient and responsive health systems for a changing world.' This commentary is the outcome of a panel discussion at the sym...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure

This study will determine whether a new form of home hemodialysis carried out at night during sleep reduces blood levels of hormone-like substances called cytokines that may cause fatigue ...

Study of the Immune Response to Hepatitis C Virus

The purpose of this study is to investigate the mechanism of a successful immune response to hepatitis C virus (HCV) infection. Currently, it is believed that the immune system is involved...

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

Group A: Long-term follow-up is needed for subjects identified as acute or early in the course of HIV-1 infection, independent of decisions regarding therapy with highly active anti-retrov...

Relation of Obesity With Frequency of Meals (MST 0557)

The purpose of this study is to test the relationship between frequency of meals and hepatic fat content and insulin sensitivity. We, the researchers at Rockefeller University, hypothesiz...

The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers

This study will evaluate how a common dietary sugar (fructose) raises blood fats (triglycerides). We will determine whether the production of fat from fructose is higher in dialysis patie...

Companies [20 Associated Companies listed on BioPortfolio]

Rockefeller & Co., Inc.

Headquartered in New York and with offices in Boston, Washington D.C. and Wilmington, Delaware, Rockefeller and Company is a leading global wealth management firm that provides comprehensive wealth an...

The Rockefeller Foundation

Blanchette Rockefeller Neurosciences Institute

Blanchette Rockefeller Neurosciences Institute (BRNI)

Venrock Associates

Venrock was founded as the venture capital arm of the Rockefeller Family and continues a six-decade tradition of funding outstanding entrepreneurs and establishing successful, enduring companies. Venr...

More Information about "Rockefeller & Co., Inc." on BioPortfolio

We have published hundreds of Rockefeller & Co., Inc. news stories on BioPortfolio along with dozens of Rockefeller & Co., Inc. Clinical Trials and PubMed Articles about Rockefeller & Co., Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rockefeller & Co., Inc. Companies in our database. You can also find out about relevant Rockefeller & Co., Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record